bioecon Member area
Technology · Biochemistry & industrial biotech / Specialty & fine chemicals

Probiotic oral care

Live-bacteria lozenges and dissolving tablets that seed the oral cavity with health-associated commensals — BLIS Technologies' Streptococcus salivarius K12/M18 (NZ), ProBiora Health's ProBiora3 (S. oralis/uberis/rattus), BioGaia's Lactobacillus reuteri Prodentis (licensed into Sunstar's GUM PerioBalance) — paired with Bristle's shotgun-sequencing oral-microbiome diagnostics.

Maturity 5/9 Risk: low Cosmetics US · CN · EU Science: why it works → verified 2026-07-28 · 6 Sources (0 independent)

1 · What it gives

Probiotic oral care seeds the mouth with live, health-associated commensal bacteria — typically delivered as a daily dissolving lozenge or chewable tablet — so that beneficial strains outcompete the species that drive caries, gingivitis and halitosis. The segment is built on named strains rather than wellness claims: BLIS Technologies’ two Streptococcus salivarius strains K12 (a bacteriocin producer active against breath and upper- respiratory pathogens) and M18 (which limits the biofilm behind caries), ProBiora Health’s patented 3-strain ProBiora3 blend (S. oralis, S. uberis, S. rattus), and BioGaia’s Lactobacillus reuteri Prodentis — two patented strains (ATCC PTA 5289 and DSM 17938) backed by 30+ years of research and licensed into Sunstar’s GUM PerioBalance. The evidence base is active: four new peer-reviewed studies on S. salivarius K12/M18 appeared in the first half of 2026. A diagnostics layer — Bristle’s at-home shotgun-sequencing test — reads the oral microbiome to target intervention.

The key directions of probiotic oral care are:

  1. Named-strain S. salivarius probiotics: BLIS K12 (breath and upper respiratory, via bacteriocin production) and M18 (caries/biofilm control).
  2. Multi-strain competitive-exclusion blends: ProBiora3 (3 oralis-group streptococci) and Hyperbiotics Pro-Dental, occupying adhesion niches to crowd out pathogens.
  3. L. reuteri gum-health lozenges: BioGaia Prodentis (2 patented strains), licensed into Sunstar’s GUM PerioBalance.
  4. Oral-microbiome diagnostics: Bristle’s shotgun DNA sequencing scores caries, gingivitis/periodontitis and halitosis risk to guide use.

Sectoral value chain#

[strain banking] ──> [fermentation] ──> [lyophilization] ──> [tableting]
                                           │
                                   (stabilized live CFU)
                                           │
                                           ▼
[daily regimen] <─── [retail / DTC] <─────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Strain isolation & bankingisolate health-associated oral commensalsIn: healthy-patient oral samples. Out: master bank vials.
Fermentation & biomassgrow strains to target density in bioreactorsIn: media, starter culture. Out: liquid cell concentrate.
Stabilization (lyophilization)freeze-dry cells into stable powderIn: cell concentrate, cryoprotectant. Out: live-CFU powder.
Formulation & tabletingblend into lozenges or dissolving tabletsIn: CFU powder, excipients, flavour. Out: finished SKU.
Clinical validationRCT and bacteriocin/biofilm assaysIn: product, trial protocol. Out: efficacy evidence.
Retail / DTC deliverydaily-regimen sale to consumersIn: packaged SKU. Out: consumer oral-health outcome.

Cross-cutting technologies of the sector:

  • Bacteriocin-producing cocci (Bacteriocin-Producing Cocci): S. salivarius K12 secretes lantibiotic-class bacteriocins that inhibit Streptococcus pyogenes and related pathogens.
  • Competitive-exclusion strain blending (Competitive-Exclusion Blending): combining oralis-group streptococci or L. reuteri pairs to occupy adhesion sites and deplete pathogen substrates.
  • Oral-microbiome shotgun sequencing (Oral-Microbiome Sequencing): metagenomic readout of the oral bacterial/fungal community for risk scoring.

2 · What it replaces 3 · matched by industry

D3E2Biodegradable scrub particles and exfoliants instead of polyethylene microbeads
Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu …
COSM
D1E–Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS
Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, …
COSM
D1E–Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen
Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their …
COSM

3 · How to implement 6 steps

  1. 1
    Strain isolationStrains & cell lines
    Health-associated commensals — S. salivarius K12/M18 or L. reuteri ATCC PTA 5289/DSM 17938 — are isolated from the oral cavity of healthy donors and master-banked.
    Who can do this step matched automatically
    Bloomage Biotechnology China
    ✓ GMP 320 tons industrial scale
    “[About Bloomage Biotech - 华熙生物 — Bloomage Biotech is a leading biotechnology and biomanufacturing company founded in 2000, focused on innovative synthetic biology with an …”
    Bota Bio 恩和生物 China
    ✓ ISO 9001 600 tons pilot scale
    “By integrating end-to-end capabilities in AI, synthetic biology, and industrialization, Bota pioneers a new paradigm in biomanufacturing research and production.”
    Esco Aster Singapore
    ✓ ISO 9001 5,000 L industrial scale
    “Platform and capabilities: end-to-end support from discovery to market approvals, with services spanning cell line creation, GMP/MO handling, CMC/PD/AD, MSAT …”
    PhaBuilder 微构工场 China
    ✓ GMP 30,000 tons/year industrial scale
    “Ultimately, it aims to realize the beautiful vision of “making PHA Life a lifestyle for thousands of households” and to implement the synthetic biology innovation path of …”
    CABIO 嘉必优 (SSE 688089) China
    ✓ ISO 9001 600 tons
    “Synthetic Biology”
  2. 2
    FermentationFermentation & cultivation
    The seed strain is grown to target cell density in a controlled bioreactor on a compatible growth medium, yielding liquid cell concentrate.
    Who can do this step matched automatically
    Loopworm India
    ✓ GMP 6,000 tonnes/year industrial scale
    “At Loopworm, we are building the future of sustainable biomanufacturing.”
    Bloomage Biotechnology China
    ✓ GMP 320 tons industrial scale
    “Bloomage Biotechnology Corporation Limited (Bloomage Biotech, SSE STAR: 688363) is a China-based biotech/biomanufacturing company using fermentation and cross-link technologies to …”
    Bota Bio 恩和生物 China
    ✓ ISO 9001 600 tons pilot scale
    “Bota Biosciences is a global leader in Physical AI-driven biomanufacturing, dedicated to making biotechnology a reliable and scalable engine of productivity.”
    Angel Yeast 安琪酵母 (SSE 600298) China
    ✓ GMP ✓ ISO 9001 228,000 tons
    “[Angel Yeast’s 8,500-Ton Specialty Yeast Facility Comes Online, Powering a New Engine for Global Biomanufacturing - Company - Angelyeast”
    Ajinomoto Japan
    ✓ GMP industrial scale
    “It specializes in amino acid fermentation technology, applying it to seasonings, processed foods, frozen foods, and healthcare solutions.”
    Esco Aster Singapore
    ✓ ISO 9001 5,000 L industrial scale
    “TideMotion® Bioreactors”
  3. 3
    LyophilizationPurification & downstream
    The concentrate is freeze-dried with a cryoprotectant into a stable live-CFU powder that holds viability through shelf storage.
    Who can do this step matched automatically
    Esco Aster Singapore
    ✓ ISO 9001 5,000 L industrial scale
    “Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
    Advanced Enzyme Technologies (NSE) India
    ✓ GMP ✓ ISO 9001 500 m3
    “Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
    GenScript ProBio / Genscript China
    ✓ GMP industrial scale
    “testing, including mass spectrometry and analytical high performance liquid chromatography”
  4. 4
    Tableting
    The CFU powder is blended with excipients and mint flavour and pressed into a dissolving lozenge or chewable tablet, the format that maximizes oral-cavity residence time.
  5. 5
    Clinical validationTesting & analytics
    The finished SKU is tested in a randomized trial and in bacteriocin/biofilm assays — e.g. Sunstar’s GUM PerioBalance is the subject of registered trial NCT07443410.
    Who can do this step matched automatically
    Esco Aster Singapore
    ✓ ISO 9001 5,000 L industrial scale
    “Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”
    Bloomage Biotechnology China
    ✓ GMP 320 tons industrial scale
    “The company positions MitoEGT® as a mitochondria-targeting anti-aging ingredient with multiple efficacy studies, 38 patents, national metrology recognition, and plans to broaden …”
    GenScript ProBio / Genscript China
    ✓ GMP industrial scale
    “ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”
    BRAIN Biotech Germany
    ✓ ISO 9001 industrial scale
    “As a contract research organization (CRO), we provide smart, rapid, and effective solutions using cutting-edge technologies to drive customer success.”
  6. 6
    Retail / DTC regimenDistribution & market access
    The product reaches the consumer as a once-daily dissolving tablet (ProBiora, BioGaia Prodentis) or chewable (Hyperbiotics Pro-Dental), supported by Bristle’s sequencing test for targeted use.
    Who can do this step matched automatically
    Rossari Biotech (NSE) India
    ✓ ISO 9001 industrial scale
    “role: distributor”
    Bloomage Biotechnology China
    ✓ GMP 320 tons industrial scale
    “role: distributor”
    GEA Group Germany
    ✓ ISO 9001
    “[Document search [Events & webinars [Farm Technologies dealer login [GEA merchandise shop [GEA videos”
    Paul Mueller Company United States
    ✓ GMP
    “[Dealer Insights from Cornes AG”
    Giant Biogene Holding China
    ✓ ISO 22716
    “role: distributor”

4 · Who delivers

Matched suppliers (matched automatically)

HLB Genex (ex-GenoFocus)South KoreaProduceractive

In the services and supply catalogue 1 · paid service

Contract manufacturing (CMO/CDMO/toll)

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
BLIS Technologies🇳🇿 New ZealandS. salivarius K12/M18 oral probioticsbacteriocin-producing cocci, breath + caries strains, 4 studies H1 2026Commercial
ProBiora Health🇺🇸 USAProBiora3 dissolving tabletsS. oralis/uberis/rattus 3-strain blend, 1 tablet/dayCommercial
Bristle🇺🇸 USAOral microbiome testshotgun DNA sequencing, caries/gingivitis/halitosis scoringCommercial
BioGaia🇸🇪 SwedenProdentis lozengesL. reuteri ATCC PTA 5289 + DSM 17938, 30+ yrs researchCommercial
Hyperbiotics🇺🇸 USAPro-Dental chewable tabletsclinically studied strain blend, plaque reductionCommercial
Sunstar🇨🇭 SwitzerlandGUM PerioBalance lozengesL. reuteri Prodentis (BioGaia-licensed), trial NCT07443410Commercial

5 · Rules & route to market

Route into Russia / EAEU: COSM · EAEU conformity bodies (Rospotrebnadzor for SGR)
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

The US is the largest single market and the home of the competitive-exclusion blend segment, with BLIS’s K12/M18 strains widely distributed across US probiotic shelves.

named-strain pioneers, multi-strain blends, oral-microbiome diagnostics#

  • BLIS Technologies (NZ, US-marketed): the strain-science pioneer — Streptococcus salivarius K12 and M18, with four new peer-reviewed studies landed in the first half of 2026.
  • ProBiora Health: the patented 3-strain ProBiora3 blend (S. oralis, S. uberis, S. rattus) as a once-daily dissolving tablet for breath, teeth, gums and natural whitening.
  • Hyperbiotics: Pro-Dental chewable tablets using clinically studied strains to lessen plaque build-up across the mouth and digestive tract.
  • Bristle: an at-home oral-microbiome DNA (shotgun) sequencing test scoring caries, gingivitis/periodontitis and halitosis risk — the diagnostics layer.
European Union

Europe anchors the Lactobacillus reuteri gum-health line, with BioGaia’s Prodentis strains — developed over 30+ years of research — licensed into Sunstar’s GUM PerioBalance.

L. reuteri Prodentis, strain licensing, clinical trials#

  • BioGaia (Sweden): Prodentis lozenges carrying two patented L. reuteri strains (ATCC PTA 5289 and DSM 17938), backed by 30+ years of probiotic research.
  • Sunstar (Switzerland/Japan): GUM PerioBalance lozenges built on L. reuteri Prodentis strains licensed from BioGaia, with a registered clinical trial (NCT07443410).
  • EU food-supplement framing: EFSA treats oral probiotics as food supplements (or novel food for new strains), distinct from the US DSHEA supplement track.
China

China’s oral-probiotic segment is emerging but still brand-thin on named-strain science: the shelf is dominated by toothpastes carrying generic “probiotic” claims rather than dedicated named-strain lozenges, so the regional picture is qualitative rather than vendor-led.

probiotic-toothpaste claims, emerging supplements, regulatory boundary#

  • NMPA health-food / cosmetics boundary: oral probiotics are regulated as health-food or cosmetics depending on claim, with named-strain health-food approvals still scarce.
  • Probiotic toothpaste incumbents: established oral-care brands add generic lactobacillus/bifidobacterium claims to toothpaste, not dedicated dissolving-tablet regimens.
  • Limited named-strain leaders: no Chinese originator of a K12/M18- or Prodentis-equivalent named-strain product has scaled, so the category imports strain science.

6 · Money: tenders & grants

GrantDeveloping novel recycling technologies for complex plastic materials applying biotech solutions
European Commission · EU
Sep 22, 2027
341 days
GrantSEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY
Advanced Research Projects Agency Energy · United States
Sep 29, 2029
1079 days
GrantTextile circularity through advanced processing and manufacturing technologies and system approaches (IA) …
European Commission · EU
Feb 2, 2027
109 days

7 · Tech stack & innovations

The stack is built on three microbiological platforms: bacteriocin-producing oral commensals, multi-strain competitive-exclusion blends, and metagenomic readout of the oral cavity.

  1. Bacteriocin-producing S. salivarius (Bacteriocin-Producing S. salivarius):
    • K12 secretes lantibiotic-class bacteriocins that inhibit Streptococcus pyogenes and other upper-respiratory pathogens; M18 limits caries-associated biofilm.
    • case: BLIS Technologies’ two-strain platform, with four new peer-reviewed studies in H1 2026.
  2. Competitive-exclusion blends (Competitive-Exclusion Blends):
    • oralis-group streptococci and paired L. reuteri occupy adhesion niches and deplete pathogen substrates rather than killing them.
    • case: ProBiora3’s 3-strain blend and BioGaia’s 2-strain L. reuteri Prodentis (licensed to Sunstar GUM PerioBalance).
  3. Oral-microbiome shotgun sequencing (Oral-Microbiome Sequencing):
    • metagenomic sequencing of the oral bacterial and fungal community quantifies caries, gingivitis and halitosis risk to guide probiotic use.
    • case: Bristle’s at-home saliva test with DNA-based risk scoring.

Sources 6 · 0 independent · 6 producer sites

Producers' own sites 6

  1. Blis technologies producer checked 2026-06-25 · link not kept
  2. Probiora health producer checked 2026-03-12 · link not kept
  3. Bristle producer checked 2026-05-02 · link not kept
  4. Biogaia producer checked 2026-06-23 · link not kept
  5. Hyperbiotics producer checked 2026-03-12 · link not kept
  6. Sunstar producer checked 2026-04-29 · link not kept